QualityStocksNewsBreaks Archives - Page 377 of 1423

WednesdaySep 21, 2022 11:25 am

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) to Take the Spotlight with a Robot Show in Sterling, Virginia

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced that its Robot Roadshow will land at 22895 Ladbrook Drive in Sterling, Virginia, on Sept. 20-21, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Robot Roadshow has made 56 landings in 22 states and Washington, D.C., to date. Knightscope’s crime-fighting robots tour the U.S. in a space-age, NASA-like ‘pod’ allowing attendees to experience all the technology that is enabling…

TuesdaySep 20, 2022 3:19 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Releases New Video Exploring Its Technologies, Progress of AIMIGo(TM) Device

HeartBeam (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector ECG platform for heart attack detection anytime, anywhere. The company today announced that, in conjunction with its upcoming virtual roadshow webinar taking place at 4:30 p.m. ET on Tuesday, Sept. 20, 2022, it has released a new video that takes viewers behind the scenes for a featured look at the HeartBeam AIMIGo technology. “This new video provides a compelling overview and explanation of our technologies and highlights our continued progress toward making the AIMIGo device available for remote heart attack detection,” said Branislav Vajdic,…

TuesdaySep 20, 2022 2:26 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Hypertension Drug Market with Proprietary Drug-Delivery Method

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is focused on establishing a stronghold in the $28 billion hypertension drug market. The company’s exclusive therapeutic, DehydraTECH-CBD, has shown exciting potential as an alternative to traditional cannabidiol (“CBD”) dosing methods; the proprietary treatment may offer improved and more rapid absorption of drugs into the bloodstream and brain. According to the announcement, only one FDA-approved CBD drug is currently available on the market; that drug is for pediatric epilepsy. Lexaria is working to offer the second-ever, FDA-approved CBD therapeutic, designed to treat hypertension. The market for the treatment is tremendous,…

TuesdaySep 20, 2022 1:41 pm

QualityStocksNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces R&B Milestones, Beats Anticipated Timeframe

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), has successfully reached key research and development (“R&D”) milestones that were identified in the company’s acquisition agreement of Adelia Therapeutics in 2020. The milestones were reached faster than expected, and have helped Cybin make progress on its path toward clinical drug development. The milestones were key in moving Cybin’s psychedelic programs from lab to clinic and have enabled the company to discover potential new drug formulations and delivery methods as well as create clinical protocols for psychedelic compounds and support clinical-stage development of CYBN’s proprietary CYB003…

TuesdaySep 20, 2022 10:37 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Release FY 2022 Financial Report, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, will be releasing its financial report for fiscal year 2022, the period ended June 30, 2022, later this month. The company has announced that it will release the financial report, along with business highlights, on Sept. 23, 2022. In addition, the company has announced a conference call and webcast to be held the same day at 1 p.m. ET. Those interested in listening in on the conference call can register for the call; they will then receive information about how to dial in to the…

MondaySep 19, 2022 12:54 pm

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Targeting $50-60M Annual Revenue from Production of 2M Gigajoules of RNG

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) is an emerging renewable natural gas (“RNG”) supply leader and organics processor in Canada creating a cluster of facilities to leverage both attractive organic feedstock tip fees and long-term RNG pricing. “EverGen’s first three owned and operated facilities – Net Zero Waste Abbotsford (‘NZWA’), Sea to Sky Soils (‘SSS’), Fraser Valley Biogas (‘FVB’) – are in southern British Columbia, with the company expanding into Alberta and Ontario in 2022 to capitalize on new opportunities in strategic jurisdictions,” a recent article reads. “EverGen has goals of its own, including estimates to generate $50-$60 million in revenue…

MondaySep 19, 2022 12:26 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Leveraging Lightning Network to Offer Better Solutions

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) is focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network (“LN”). The company is at the forefront of making micropayment transactions quick and affordable for consumers by leveraging its Bitcoin assets to create the channels necessary to facilitate growth across the LN. “LQwD has expanded its reach, providing LN nodes across 17 countries and a goal of increasing its presence to 24 countries by the end of the current quarter… Collectively, these [existing] nodes offer users a capacity of over 30 BTC and access to over 300 payment channels. The…

MondaySep 19, 2022 12:17 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Removing Guesswork in Music Production, Distribution, Marketing for Indie Artists

Friendable (OTC: FDBL), a mobile technology and marketing company, is changing the dynamic for indie artists. Unlike those with mainstream record labels, indie artists do not have the same support from the industry when producing, distributing and marketing music and must rely on third parties, which can result in a search for three or more separate entities to make these endeavors possible. “One company is changing this dynamic for indie artists, making it possible for them to produce, distribute and market their music on one platform – Fan Pass Live. The platform from Friendable, accompanied by the company’s Artist Republik…

FridaySep 16, 2022 2:09 pm

QualityStocksNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Releases Pricing of Public Offering

Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, has released the pricing of its public offering. The offering consists of 3,333,333 shares of its common stock (or common stock equivalents in lieu thereof) along with warrants to purchase up to 3,333,333 additional shares of its common stock. According to the announcement, the combined offering price will be $6 per share (or common stock equivalent) and associated warrants. The company noted that in addition to the $6 per share exercise price, the warrants will be immediately exercisable with an…

FridaySep 16, 2022 1:43 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Leading Charge to Find Potential Treatment Option for GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a preclinical stage biotechnology company, is looking to fill a gap in the treatment of Glioblastoma Multiforme (“GBM”), an aggressive form of cancer that occurs in the brain or spinal cord, with its lead product candidate Berubicin. “GBM is considered one of the most complex, deadly and treatment-resistant cancers. And although it is regarded as rare, between 12,000 and 15,000 Americans are diagnosed with the condition every year. Even more devastatingly, the National Brain Tumor Society (‘NBTS’) estimates that over 10,000 individuals with GBM succumb to the disease annually. GBM has a five-year survival rate of…

Site Search

Company Search

Category: QualityStocksNewsBreaks